Nicotine activates the dopamine reward network in the brain, but at high doses it also activates a parallel aversive dopamine network. This discovery and identification of the nicotine receptor responsible for the negative effects of high-dose nicotine provides a target for drug developers. In the future, therapeutics could tweak the network to make nicotine aversive at lower doses in order to help smokers quit.